Not Tagged
merck
['improve', 'headandneck', 'scchn', 'merck']
most patients with locally advanced #headandneckcancer are being treated with curative intent, but still 50% will relapse within two years. we continue to innovate each day as we work to improve outcomes for these patients. #asco22 #scchn 
Global specialty innovator helping to create, improve and prolong life. Not intended for US&CA visitors. Imprint: https://t.co/7udzrkVbNx